The honest answer: yes, but modestly. Three independent research reviews published in 2026 — an umbrella review of 113 trials, a meta-analysis of 35 trials, and a systematic review of 25 trials — all found that oral collagen peptide supplementation is associated with real improvements in skin elasticity. None found dramatic transformations. The consistent finding across all three is that elasticity improves with regular use over weeks, not days, and the effect is moderate rather than miraculous.
That’s a more useful starting point than either “collagen is amazing” or “it’s all rubbish.”
What elasticity actually means (and why it declines)
Skin elasticity is your skin’s ability to stretch and snap back — press your cheek, let go, and the speed at which it returns is a rough measure of its elastic properties. It depends on two structural proteins in the dermis: collagen (which provides tensile strength) and elastin (which provides the actual spring-back). Both decline naturally with age — collagen production drops roughly 1–1.5% per year from your mid-twenties — and UV exposure accelerates the breakdown. The question isn’t whether collagen matters for elasticity; it’s whether eating extra collagen peptides actually helps.
The VERISOL trial: the single strongest piece of evidence
The most specific, well-designed trial on collagen and skin elasticity used VERISOL — a patented bovine bioactive collagen peptide. Published in Skin Pharmacology and Physiology (Proksch et al., 2014), it was a randomised, double-blind, placebo-controlled trial of 69 women aged 35–55. The protocol: 2.5g of VERISOL daily for 8 weeks.
The result: a statistically significant improvement in skin elasticity compared with placebo, measurable at both 4 and 8 weeks. A follow-up measurement found the effect persisted for at least 4 weeks after participants stopped taking the supplement — suggesting a real structural change rather than a temporary surface effect.
Two honest caveats. First, this is one peptide, from one manufacturer (GELITA), tested on one population (women 35–55). It doesn’t automatically generalise to every collagen source in every product. Second, the trial was funded by the manufacturer — a legitimate concern, though the study design (randomised, blinded, placebo-controlled) is about as robust as nutrition trials get.
VERISOL is the peptide used in the NOW Foods Collagen Jelly Beauty Complex tracked on this site, at the same 2.5g dose used in the trial.
What the larger reviews found about elasticity specifically
Individual trials are useful but limited. What matters more is whether the finding holds up when you look across many trials at once. In 2026, three independent research groups did exactly that — and their conclusions on elasticity converge.
The ARU umbrella review (Smith et al., Aesthetic Surgery Journal Open Forum, 2026) analysed 16 systematic reviews covering 113 randomised controlled trials and nearly 8,000 participants worldwide. On skin elasticity specifically, it found that longer supplementation was associated with greater improvements. The overall assessment: “cautiously positive.” This is the largest integrated analysis of collagen supplementation published to date.
The Batool et al. meta-analysis (Journal of Cosmetic Dermatology, 2026) looked at 35 RCTs and found meaningful improvements in both hydration and elasticity — but with an important distinction. Hydration improvements appeared from as early as 4 weeks, while elasticity improvements mainly showed at 12 weeks. They also found that treatment duration mattered more than dose: no significant linear dose-response relationship, meaning there’s no evidence that doubling the dose doubles the benefit.
The Bassila et al. systematic review (European Journal of Clinical Nutrition, Nature, 2026) covered 25 RCTs on oral collagen peptide supplementation and skin outcomes. It found consistent improvements in hydration and elasticity across studies, and noted that the underlying mechanism — bioactive dipeptides reaching dermal fibroblasts — now has stronger support than it did five years ago.
Three different research groups, three different analytical methods, published in three different peer-reviewed journals, the same year. All three found a positive signal for skin elasticity. That convergence is harder to dismiss than any single study.
The mechanism: how could eating collagen affect your skin?
This is the part sceptics reasonably question. Your body breaks down ingested collagen during digestion, so how could it possibly reach your skin intact?
The answer is that it doesn’t arrive intact — but it doesn’t break down into entirely generic amino acids either. Research has shown that specific bioactive dipeptides, particularly prolyl-hydroxyproline (Pro-Hyp), survive digestion and appear in human blood after oral collagen intake (Iwai et al., 2005, Journal of Agricultural and Food Chemistry). Separately, Ohara et al. (2010) demonstrated in Journal of Dermatological Science that Pro-Hyp stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts.
So there’s a documented mechanism: eat hydrolysed collagen → specific fragments survive digestion → those fragments reach the bloodstream → in laboratory conditions, they stimulate the cells responsible for maintaining skin structure. The gap between “works in a lab dish” and “works reliably in a living person” is real, but the mechanism isn’t hypothetical — it’s been traced step by step.
The caveats that matter
Honesty about the limitations matters as much as reporting the positive findings.
Industry funding is pervasive. Most collagen trials, including the VERISOL study, are funded by supplement manufacturers. A 2025 meta-analysis by Myung and Park in The American Journal of Medicine found that industry-funded trials reported positive effects while independently funded, higher-quality trials did not. That doesn’t invalidate the funded trials, but it’s a real concern that nobody should pretend away.
Elasticity gains are moderate, not dramatic. Nobody in any of these trials experienced a visible transformation. The improvements are measurable by instruments (cutometers, typically) rather than obvious in a mirror. “Modest improvement in a biophysical measurement over weeks” is the real finding. Supplement marketing implies much more.
Wrinkle reduction is weaker. The Batool et al. meta-analysis is particularly useful here because it separated outcomes carefully. Hydration and elasticity improved. Wrinkle reduction and dermal density — the two claims supplement marketing leans on hardest — did not survive rigorous statistical analysis. Those are different outcomes, and the evidence treats them differently.
Most trials are short. The typical duration is 8–12 weeks. Whether elasticity improvements persist, plateau, or reverse over months or years isn’t well studied. The VERISOL trial’s 4-week follow-up is one of the few data points on what happens after stopping, and it’s encouraging but limited.
What this means for jelly sticks specifically
Nothing about these reviews changes the format question — a jelly stick delivers collagen the same way a powder, sachet, or gummy does, and the evidence applies regardless of the pouch it came in. What the reviews do reinforce is that consistency over weeks matters more than dose size on any given day, which is actually the strongest practical argument for whichever format you’ll actually take daily. If you’d skip a powder but eat a jelly stick, the format might matter — not because it changes the biology, but because it changes whether you keep showing up.
Our full evidence roundup covers the broader case for and against collagen supplements. The ARU umbrella review piece goes deeper into what 113 trials found across all health outcomes, and the dermatologist sceptics’ case presents the credible counter-argument. If you’ve weighed this up and want to try one, our where-to-buy guide compares six UK-available options by dose, source, and price.